Anti-VEGF treatment strategies for wet AMD

Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid U. Scott

Research output: Contribution to journalReview article

77 Citations (Scopus)

Abstract

Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.

Original languageEnglish (US)
Article number786870
JournalJournal of Ophthalmology
Volume2012
DOIs
StatePublished - Dec 1 2012

Fingerprint

Macular Degeneration
Vascular Endothelial Growth Factor A
Endothelial Growth Factors
Appointments and Schedules
Therapeutics

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Kovach, Jaclyn L. ; Schwartz, Stephen G. ; Flynn, Harry W. ; Scott, Ingrid U. / Anti-VEGF treatment strategies for wet AMD. In: Journal of Ophthalmology. 2012 ; Vol. 2012.
@article{9f21612465ce43c39efc097d78274a3b,
title = "Anti-VEGF treatment strategies for wet AMD",
abstract = "Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.",
author = "Kovach, {Jaclyn L.} and Schwartz, {Stephen G.} and Flynn, {Harry W.} and Scott, {Ingrid U.}",
year = "2012",
month = "12",
day = "1",
doi = "10.1155/2012/786870",
language = "English (US)",
volume = "2012",
journal = "Journal of Ophthalmology",
issn = "2090-004X",
publisher = "Hindawi Publishing Corporation",

}

Anti-VEGF treatment strategies for wet AMD. / Kovach, Jaclyn L.; Schwartz, Stephen G.; Flynn, Harry W.; Scott, Ingrid U.

In: Journal of Ophthalmology, Vol. 2012, 786870, 01.12.2012.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Anti-VEGF treatment strategies for wet AMD

AU - Kovach, Jaclyn L.

AU - Schwartz, Stephen G.

AU - Flynn, Harry W.

AU - Scott, Ingrid U.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.

AB - Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.

UR - http://www.scopus.com/inward/record.url?scp=84869225440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869225440&partnerID=8YFLogxK

U2 - 10.1155/2012/786870

DO - 10.1155/2012/786870

M3 - Review article

C2 - 22523653

AN - SCOPUS:84869225440

VL - 2012

JO - Journal of Ophthalmology

JF - Journal of Ophthalmology

SN - 2090-004X

M1 - 786870

ER -